IFP Advisors’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

IFP Advisors’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-476	Closed	–	–	4289
2016 Q2	$0	Buy	+476	New	+$764	﹤0.01%	4338
2016 Q1	–	Sell	-476	Closed	-$1K	–	4531
2015 Q4	$1K	Buy	+476	New	+$2.15K	﹤0.01%	3693

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

IFP Advisors's EPRS Position: Q3 2016 in Review

IFP Advisors sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 476 shares.

IFP Advisors first reported a position in EPRS in Q4 2015 and held it in 2 quarters. The position peaked at $1K in Q4 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

IFP Advisors reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
IFP Advisors sold 476 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016.
IFP Advisors first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
IFP Advisors's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $1K in Q4 2015.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on IFP Advisors's 13F filing for Q3 2016, filed 4 Nov 2016.